Friday, February 8, 2019

TB survivors file challenge to prevent J&J from extending patent life on Bedaquiline

Advertisement
Two tuberculosis survivors have filed a patent challenge on Johnson and Johnson’s TB drug Bedaquiline.Nandita Venkatesan from Mumbai and Phumeza Tisil
Source: BHT
Share This
Previous Post
Next Post

TB survivors file challenge to prevent J&J from extending patent life on Bedaquiline - Amazon Offers, Latest News Headlines - Gameforumer